Loading...
Double-targeting Using A TrkC-Ligand Conjugated To BODIPY-based PDT Agent
A molecule 1 (IY-IY-PDT) was designed to contain a fragment (IY-IY) that targets the TrkC receptor, and a photosensitizer that acts as an agent for photodynamic therapy (PDT). Molecule 1 had sub-micromolar photocytotoxicities to cells that were either engineered to stably express TrkC (NIH3T3-TrkC)...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3837628/ https://ncbi.nlm.nih.gov/pubmed/24063347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm4012142 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|